Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Pollak

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2003
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's diseaseAurélie Funkiewiez, Claire Ardouin, Paul Krack, et al.
NMR in Biomedicine|March 6, 2007
Glutamate measurement in Parkinson's disease using MRS at 3 T field strengthNils Kickler, Paul Krack, Valérie Fraix, et al.
Journal of Neurosurgery|March 2, 2010
Effects of magnetic resonance imaging in patients with implanted deep brain stimulation systemsValerie Fraix, Stephan Chabardes, Alexandre Krainik, et al.
Comptes Rendus Biologies|March 18, 2005
Therapeutic electrical stimulation of the central nervous systemAlim-Louis Benabid, Bradley Wallace, John Mitrofanis, et al.
Parkinsonism & Related Disorders|April 30, 2013
Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's diseaseVanessa Fleury, Christian Wider, Judit Horvath, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
Interruption of deep brain stimulation of the globus pallidus in primary generalized dystoniaDavid Grabli, Claire Ewenczyk, Maria-Clara Coelho-Braga, et al.
Archives of Neurology|November 10, 2004
Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic studyStéphane Thobois, François Vingerhoets, Valerie Fraix, et al.
Journal of Neurology|September 26, 2006
Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's diseaseKathy Dujardin, David Devos, Stéphane Duhem, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2006
Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's diseaseAurélie Funkiewiez, Claire Ardouin, Roshan Cools, et al.
Frontiers in Aging Neuroscience|August 8, 2014
Dopaminergic modulation of emotional conflict in Parkinson's diseaseVanessa Fleury, Emilie Cousin, Virginie Czernecki, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2003
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's diseaseAurélie Funkiewiez, Claire Ardouin, Paul Krack, et al.
NMR in Biomedicine|March 6, 2007
Glutamate measurement in Parkinson's disease using MRS at 3 T field strengthNils Kickler, Paul Krack, Valérie Fraix, et al.
Journal of Neurosurgery|March 2, 2010
Effects of magnetic resonance imaging in patients with implanted deep brain stimulation systemsValerie Fraix, Stephan Chabardes, Alexandre Krainik, et al.
Comptes Rendus Biologies|March 18, 2005
Therapeutic electrical stimulation of the central nervous systemAlim-Louis Benabid, Bradley Wallace, John Mitrofanis, et al.
Parkinsonism & Related Disorders|April 30, 2013
Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's diseaseVanessa Fleury, Christian Wider, Judit Horvath, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
Interruption of deep brain stimulation of the globus pallidus in primary generalized dystoniaDavid Grabli, Claire Ewenczyk, Maria-Clara Coelho-Braga, et al.
Archives of Neurology|November 10, 2004
Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic studyStéphane Thobois, François Vingerhoets, Valerie Fraix, et al.
Journal of Neurology|September 26, 2006
Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's diseaseKathy Dujardin, David Devos, Stéphane Duhem, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2006
Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's diseaseAurélie Funkiewiez, Claire Ardouin, Roshan Cools, et al.
Frontiers in Aging Neuroscience|August 8, 2014
Dopaminergic modulation of emotional conflict in Parkinson's diseaseVanessa Fleury, Emilie Cousin, Virginie Czernecki, et al.
Pageof 13